Wednesday, November 11, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 21, 2026

3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes

View original at finance.yahoo.com
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes The Medical Info Systems industry continues to expand rapidly, driven by innovations in healthcare resource management, patient data handling and integrated digital care delivery…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 79% of health systems reported increasing their investments in digital health solutions over the past two years

    80% confidence
  • Medical Info Systems industry carries Zacks Industry Rank #161, placing it in bottom 34% of 244 Zacks industries, indicating dull near-term prospects

    80% confidence
  • Top 50% of Zacks-ranked industries outperform bottom 50% by a factor of more than 2 to 1

    80% confidence
  • Global Smart Healthcare Products market was valued at $280.48 billion in 2024 and is expected to reach $796.36 billion by 2032, at a CAGR of 15.37%

    80% confidence
  • Doximity has 95% subscription-based revenue model with strong net revenue retention

    80% confidence
  • Doximity is expanding across a $18.55 billion total addressable market

    80% confidence
  • The use of AI in healthcare market is expected to witness a CAGR of 38.6% during 2025-2030, propelled by growing demand for enhanced diagnostic accuracy, optimized workflows and personalized medicine

    80% confidence
  • Omnicell's revenues expected to witness 2.8% CAGR during 2025-2027

    80% confidence
  • In 2025, ransomware and cyberattacks rose sharply, increasingly targeting healthcare organizations and service partners, disrupting operations and exposing patient data

    80% confidence
  • Doximity covers over 80% of U.S. doctors and 60% of advanced practitioners

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes — Source | Via News | Via News